Clinical Trial Update: Depression and Health Outcomes in Refractory Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing depression and health outcomes in patients with refractory epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Major Depressive Disorder

Snippet

Sponsor: Columbia University | Conditions: Depression, Epilepsy | Phase 3 | Status: COMPLETED